Primary Record
benfotiamine
- In stock
- 2,684 g
- Purity
- 98.2 %
- CAS
- 22457-89-2
Compound Identifiers & Properties
- CAS
- 22457-89-2
- PubChem CID
- 5282168
- SMILES
- CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(\CCOP(=O)(O)O)/SC(=O)C2=CC=CC=C2)/C
- Canonical SMILES
- C/C(=C(/CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N
Names & Synonyms
- benfotiamine
- Biotamin
- Benfotiaminum
- Benphothiamine
- Benfotiamina
- Nitanevril
- Vitanevril
- Betivina
- Bietamine
- Biotinin
- Neurostop
- Tabiomyl
- Biotowa
- Berdi
- Foti
- BTMP
- S-Benzoylthiamine O-monophosphate
- AC1NQZLE
- 22457-89-2
- Benfotiamine (Standard)
- AC1Q6RZY
- Benzoylthiamine monophosphate
- Spectrum5_001042
- UNII-Y92OUS2H9B
- Benfotiaminum [INN-Latin]
- Benfotiamina [INN-Spanish]
- C19H23N4O6PS
- Thiamine monophosphate benzoyl
- SPECTRUM1503105
- Benfotiamine [DCF:INN:JAN]
- Benfotiamine [INN:DCF:JAN]
- Benzoylthiamine O-monophosphate
- S-Benzoylthiamine monophosphate
- SCHEMBL23510243
- HMS500J09
- S-Benzoylthiamine-O-monophosphate
- MFCD00057343
- HMS1923I13
- Pharmakon1600-01503105
- BCP13283
- ZINC2015558
- EINECS 245-013-4
- AR-1L3714
- CCG-39303
- HY-17374R
- NSC758241
- s4798
- ''S''-benzoylthiamine O-monophosphate
- AKOS016339593
- C19-H23-N4-O6-P-S
- 8088 C.B.
- CB 8088
- CID5282168
- CS-1054
- J3.153D
- KS-5205
- NSC-758241
- BRN 0771326
- IDI1_000187
- NCGC00016764-01
- NCGC00016764-02
- NCGC00016764-03
- NCGC00095259-01
- NCGC00095259-02
- HY-17374
- SBI-0051900.P002
- CAS-22457-89-2
- FT-0630486
- D81796
- W-5056
- AB00052426_02
- AB00052426_03
- 457B892
- BRD-K02571615-001-01-8
- BRD-K07359318-001-03-9
- BRD-K07359318-396-01-7
- S-(2-(N-((4-Amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl) benzothioate
- s-[2-{[(4-amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-5-(phosphonooxy)pent-2-en-3-yl] benzenecarbothioate
- (4-{N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamido}-3-(benzoylsulfanyl)pent-3-en-1-yl)oxyphosphonic acid
- [(4-{N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamido}-3-(benzoylsulfanyl)pent-3-en-1-yl)oxy]phosphonic acid
- {[(3E)-4-{N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamido}-3-[(E)-benzoylsulfanyl]pent-3-en-1-yl]oxy}phosphonic acid
- 23002-99-5
- Benzenecarbothioic acid, S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propen-1-yl] ester; Benzenecarbothioic acid, S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl] ester (9CI); Benzoic acid, thio-, S-ester with N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)formamide dihydrogen phosphate (ester) (8CI); Formamide, N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)-, S-benzoate O-(dihydrogen phosphate) (8CI); 8088CB; BTMP; Benfothiamine; Benfotiamine; Benzoylthiamine O-monophosphate; Benzoylthiamine monophosphate; Berdi; Betivina; Bietamine; Biotamin; Milgamma; N-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)formamide S-benzoate O-phosphate; Neurostop; Nitanevril; S-Benzoylthiamine O-monoph
- Benzenecarbothioic acid, S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl] ester
- S-(2-(N-((4-Amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl)benzothioa
- S-[(E)-2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-1-(2-phosphonooxyethyl)prop-1-enyl] benzenecarbothioate
- S-[(E)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate
- Thiobenzoic acid S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl]
- Thiobenzoic acid S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl] ester
- Thiobenzoic acid S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-5-(phosphonooxy)-2-penten-3-yl] ester